These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9652571)

  • 21. Metabolomic analysis reveals novel isoniazid metabolites and hydrazones in human urine.
    Li F; Miao Y; Zhang L; Neuenswander SA; Douglas JT; Ma X
    Drug Metab Pharmacokinet; 2011; 26(6):569-76. PubMed ID: 21844656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient knows best: blinded assessment of nonadherence with antituberculous therapy by physicians, nurses, and patients compared with urine drug levels.
    Macintyre CR; Goebel K; Brown GV
    Prev Med; 2005 Jan; 40(1):41-5. PubMed ID: 15530579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antituberculous agents. Isoniazid, rifampin, streptomycin, ethambutol, and pyrazinamide.
    Van Scoy RE; Wilkowske CJ
    Mayo Clin Proc; 1983 Apr; 58(4):233-40. PubMed ID: 6834890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Signes of adaptation under long-term combined antituberculous therapy (author's transl)].
    Regli J; Ziegler WJ
    Schweiz Rundsch Med Prax; 1974 Jan; 63(2):49-50. PubMed ID: 4212815
    [No Abstract]   [Full Text] [Related]  

  • 25. A simplified method for detecting isoniazid compliance in patients receiving antituberculosis chemotherapy.
    Hashiguchi M; Ohno K; Sakuma A; Hino F; Tanaka T; Ohtsuji M; Matsumoto N; Yanase K; Urae A; Hosogai Y; Sato N; Yazaki A; Matsuda K; Yamazaki K; Rikihisa T
    J Clin Pharmacol; 2002 Feb; 42(2):151-6. PubMed ID: 11831537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of tuberculosis].
    Broquié G
    Soins; 1978 Sep; 23(17):25-8. PubMed ID: 249574
    [No Abstract]   [Full Text] [Related]  

  • 27. Update on the treatment of tuberculosis.
    Inge LD; Wilson JW
    Am Fam Physician; 2008 Aug; 78(4):457-65. PubMed ID: 18756652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy of extrapulmonary tuberculosis].
    Zhang YS
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Jun; 14(3):181-3. PubMed ID: 1913971
    [No Abstract]   [Full Text] [Related]  

  • 29. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. For whom the bell tolls: isoniazid preventive therapy and tuberculosis drug resistance.
    Cobelens FG
    Sci Transl Med; 2013 Apr; 5(180):180fs12. PubMed ID: 23576813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of tuberculosis in the 1980s.
    Jones FL
    Pa Med; 1983 Feb; 86(2):36-40. PubMed ID: 6682542
    [No Abstract]   [Full Text] [Related]  

  • 32. 4-, 5- and 6-month regimens containing isoniazid, rifampicin, pyrazinamide and streptomycin for treatment of pulmonary tuberculosis under program conditions in Hong Kong.
    Chan SL; Wong PC; Tam CM
    Tuber Lung Dis; 1994 Aug; 75(4):245-50. PubMed ID: 7949069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
    Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug therapy of pulmonary tuberculosis].
    Forschbach G
    Prax Klin Pneumol; 1978 Dec; 32(12):749-68. PubMed ID: 103085
    [No Abstract]   [Full Text] [Related]  

  • 35. No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in Southeast Asian refugees and migrants: completion and compliance are major determinants of effectiveness.
    MacIntyre CR; Ansari MZ; Carnie J; Hart WG
    Prev Med; 2000 May; 30(5):425-32. PubMed ID: 10845752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical practice. Latent tuberculosis infection.
    Jasmer RM; Nahid P; Hopewell PC
    N Engl J Med; 2002 Dec; 347(23):1860-6. PubMed ID: 12466511
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of tuberculosis.
    Lordi GM; Reichman LB
    Am Fam Physician; 1991 Jul; 44(1):219-24. PubMed ID: 2058533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the 3-drug combination, Rifater, versus 4-drug therapy in the ambulatory treatment of tuberculosis in Cape Town.
    Macnab MF; Bohmer PD; Seager JR
    S Afr Med J; 1994 Jun; 84(6):325-8. PubMed ID: 7740377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reliability and practicality of the Arkansas method assay of isoniazid adherence.
    Schmitz KE; Hovell MF; Wong CA; Kelley NJ; Nilsen D; Blumberg EJ; Hill LL; Sipan CL; Kolody B; Chatfield DA
    Clin Nurs Res; 2010 May; 19(2):131-43. PubMed ID: 20435784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The new combined antituberculous drug: the original combined antituberculous drug dioxazid].
    Glushkov RG; Sokolova GB; Krylova LIu; Stebaeva LF; Sharova SA
    Probl Tuberk Bolezn Legk; 2007; (3):20-5. PubMed ID: 17500222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.